FASLG and pulmonary fibrosis: This study reveals that phaseoloidin promotes autophagy in myofibroblasts through activating AMPK, thereby reducing collagen deposition in pulmonary fibrosis, and exerts anti-pulmonary-fibrosis effects by degrading PTPN13 and relieving myofibroblasts of apoptotic resistance to FasL.